Literature DB >> 26540406

X chromosome reactivation in reprogramming and in development.

Vincent Pasque1, Kathrin Plath2.   

Abstract

Dramatic epigenetic changes take place during mammalian differentiation from the naïve pluripotent state including the silencing of one of the two X chromosomes in female cells through X chromosome inactivation. Conversely, reprogramming of somatic cells to naive pluripotency is coupled to X chromosome reactivation (XCR). Recent studies in the mouse system have shed light on the mechanisms of XCR by uncovering the timing and steps of XCR during reprogramming to induced pluripotent stem cells (iPSCs), allowing the generation of testable hypotheses during embryogenesis. In contrast, analyses of the X chromosome in human iPSCs have revealed important differences between mouse and human reprogramming processes that can partially be explained by the establishment of distinct pluripotent states and impact disease modeling and the application of human pluripotent stem cells. Here, we review recent literature on XCR as a readout and determinant of reprogramming to pluripotency.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26540406      PMCID: PMC4688236          DOI: 10.1016/j.ceb.2015.10.006

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  84 in total

Review 1.  X inactivation and the complexities of silencing a sex chromosome.

Authors:  Jennifer Chow; Edith Heard
Journal:  Curr Opin Cell Biol       Date:  2009-05-26       Impact factor: 8.382

2.  Whole-genome bisulfite sequencing of two distinct interconvertible DNA methylomes of mouse embryonic stem cells.

Authors:  Ehsan Habibi; Arie B Brinkman; Julia Arand; Leonie I Kroeze; Hindrik H D Kerstens; Filomena Matarese; Konstantin Lepikhov; Marta Gut; Isabelle Brun-Heath; Nina C Hubner; Rosaria Benedetti; Lucia Altucci; Joop H Jansen; Jörn Walter; Ivo G Gut; Hendrik Marks; Hendrik G Stunnenberg
Journal:  Cell Stem Cell       Date:  2013-07-11       Impact factor: 24.633

3.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

Review 4.  X-inactivation, imprinting, and long noncoding RNAs in health and disease.

Authors:  Jeannie T Lee; Marisa S Bartolomei
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

5.  Derivation of naive human embryonic stem cells.

Authors:  Carol B Ware; Angelique M Nelson; Brigham Mecham; Jennifer Hesson; Wenyu Zhou; Erica C Jonlin; Antonio J Jimenez-Caliani; Xinxian Deng; Christopher Cavanaugh; Savannah Cook; Paul J Tesar; Jeffrey Okada; Lilyana Margaretha; Henrik Sperber; Michael Choi; C Anthony Blau; Piper M Treuting; R David Hawkins; Vincenzo Cirulli; Hannele Ruohola-Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-12       Impact factor: 11.205

6.  Direct cell reprogramming is a stochastic process amenable to acceleration.

Authors:  Jacob Hanna; Krishanu Saha; Bernardo Pando; Jeroen van Zon; Christopher J Lengner; Menno P Creyghton; Alexander van Oudenaarden; Rudolf Jaenisch
Journal:  Nature       Date:  2009-11-08       Impact factor: 49.962

7.  Histone variant macroH2A marks embryonic differentiation in vivo and acts as an epigenetic barrier to induced pluripotency.

Authors:  Vincent Pasque; Aliaksandra Radzisheuskaya; Astrid Gillich; Richard P Halley-Stott; Maryna Panamarova; Magdalena Zernicka-Goetz; M Azim Surani; José C R Silva
Journal:  J Cell Sci       Date:  2012-10-17       Impact factor: 5.285

8.  X chromosome activity in mouse XX primordial germ cells.

Authors:  Susana M Chuva de Sousa Lopes; Katsuhiko Hayashi; Tanya C Shovlin; Will Mifsud; M Azim Surani; Anne McLaren
Journal:  PLoS Genet       Date:  2008-02       Impact factor: 5.917

9.  Differentiation-dependent requirement of Tsix long non-coding RNA in imprinted X-chromosome inactivation.

Authors:  Emily Maclary; Emily Buttigieg; Michael Hinten; Srimonta Gayen; Clair Harris; Mrinal Kumar Sarkar; Sonya Purushothaman; Sundeep Kalantry
Journal:  Nat Commun       Date:  2014-06-30       Impact factor: 14.919

10.  Resetting transcription factor control circuitry toward ground-state pluripotency in human.

Authors:  Yasuhiro Takashima; Ge Guo; Remco Loos; Jennifer Nichols; Gabriella Ficz; Felix Krueger; David Oxley; Fatima Santos; James Clarke; William Mansfield; Wolf Reik; Paul Bertone; Austin Smith
Journal:  Cell       Date:  2014-09-11       Impact factor: 41.582

View more
  24 in total

Review 1.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

Review 2.  X-chromosome dosage as a modulator of pluripotency, signalling and differentiation?

Authors:  Edda G Schulz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-11-05       Impact factor: 6.237

Review 3.  Mechanisms of gene regulation in human embryos and pluripotent stem cells.

Authors:  Thorold W Theunissen; Rudolf Jaenisch
Journal:  Development       Date:  2017-12-15       Impact factor: 6.868

Review 4.  The Role of Xist in X-Chromosome Dosage Compensation.

Authors:  Anna Sahakyan; Yihao Yang; Kathrin Plath
Journal:  Trends Cell Biol       Date:  2018-06-14       Impact factor: 20.808

5.  Identification of sex-specific DNA methylation changes driven by specific chemicals in cord blood in a Faroese birth cohort.

Authors:  Yuet-Kin Leung; Bin Ouyang; Liang Niu; Changchun Xie; Jun Ying; Mario Medvedovic; Aimin Chen; Pal Weihe; Damaskini Valvi; Philippe Grandjean; Shuk-Mei Ho
Journal:  Epigenetics       Date:  2018-05-16       Impact factor: 4.528

6.  Aberrant DNA Methylation in Human iPSCs Associates with MYC-Binding Motifs in a Clone-Specific Manner Independent of Genetics.

Authors:  Athanasia D Panopoulos; Erin N Smith; Angelo D Arias; Peter J Shepard; Yuriko Hishida; Veronica Modesto; Kenneth E Diffenderfer; Clay Conner; William Biggs; Efren Sandoval; Agnieszka D'Antonio-Chronowska; W Travis Berggren; Juan Carlos Izpisua Belmonte; Kelly A Frazer
Journal:  Cell Stem Cell       Date:  2017-04-06       Impact factor: 24.633

7.  Large-Scale Profiling Reveals the Influence of Genetic Variation on Gene Expression in Human Induced Pluripotent Stem Cells.

Authors:  Christopher DeBoever; He Li; David Jakubosky; Paola Benaglio; Joaquin Reyna; Katrina M Olson; Hui Huang; William Biggs; Efren Sandoval; Matteo D'Antonio; Kristen Jepsen; Hiroko Matsui; Angelo Arias; Bing Ren; Naoki Nariai; Erin N Smith; Agnieszka D'Antonio-Chronowska; Emma K Farley; Kelly A Frazer
Journal:  Cell Stem Cell       Date:  2017-04-06       Impact factor: 25.269

8.  Characterization of X-Chromosome Gene Expression in Bovine Blastocysts Derived by In vitro Fertilization and Somatic Cell Nuclear Transfer.

Authors:  Byungkuk Min; Jung Sun Park; Kyuheum Jeon; Yong-Kook Kang
Journal:  Front Genet       Date:  2017-04-10       Impact factor: 4.599

9.  Transcription factors orchestrate dynamic interplay between genome topology and gene regulation during cell reprogramming.

Authors:  Ralph Stadhouders; Enrique Vidal; François Serra; Bruno Di Stefano; François Le Dily; Javier Quilez; Antonio Gomez; Samuel Collombet; Clara Berenguer; Yasmina Cuartero; Jochen Hecht; Guillaume J Filion; Miguel Beato; Marc A Marti-Renom; Thomas Graf
Journal:  Nat Genet       Date:  2018-01-15       Impact factor: 38.330

10.  Epigenetic reprogramming by naïve conditions establishes an irreversible state of partial X chromosome reactivation in female stem cells.

Authors:  Alexandra V Panova; Alexandra N Bogomazova; Maria A Lagarkova; Sergey L Kiselev
Journal:  Oncotarget       Date:  2018-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.